Market Cap
$136.64 M
+$7.63 M+5.91%
29 min ago
Summary:
Lineage Cell Therapeutics market capitalization is currently $136.64 million, with a rise of +$7.63 million (+5.91%) during the most recent trading day. Over the past year, it has dropped by -$38.34 million (-21.91%). LCTX market cap is now -71.91% below its all-time high of $486.42 million.LCTX Market Cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LCTX Market Cap Performance
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | TTM Dividend per shareTTM Dividend per share |
|---|---|---|---|---|
| todaytoday | +5.9% | +5.9% | +20.9% | - |
| 1 m1 month | -16.8% | -31.2% | - | - |
| 3 m3 months | -21.4% | -35.0% | - | - |
| 6 m6 months | -23.1% | -36.4% | - | - |
| ytdytd | -28.4% | -45.1% | - | - |
| 1 y1 year | -21.9% | -40.1% | +30.5% | - |
| 5 y5 years | +1.4% | -33.5% | +52.4% | - |
LCTX Market Cap High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $183 M | -25.4% | $119 M | +15.1% |
| 3 m | 3 months | $183 M | -25.4% | $119 M | +15.1% |
| 6 m | 6 months | $204 M | -33.0% | $119 M | +15.1% |
| 1 y | 1 year | $281 M | -51.4% | $119 M | +15.1% |
| 3 y | 3 years | $452 M | -69.8% | $119 M | +15.1% |
| 5 y | 5 years | $486 M | -71.9% | $81 M | +68.9% |
| alltime | all time | $486 M | -71.9% | $3.57 M | +3723.0% |
Lineage Cell Therapeutics Market Cap History
| Date | Value |
|---|---|
| 2024 | $136.64 M(-28.4%) |
| 2023 | $190.74 M(-4.2%) |
| 2022 | $199.01 M(-52.1%) |
| 2021 | $415.22 M(+54.1%) |
| 2020 | $269.45 M(+102.1%) |
| 2019 | $133.33 M(+15.2%) |
| 2018 | $115.69 M(-57.6%) |
| 2017 | $272.76 M(-26.5%) |
| 2016 | $371.02 M(+0.1%) |
| 2015 | $370.73 M(+27.1%) |
| 2014 | $291.79 M(+42.9%) |
| 2013 | $204.17 M(+31.7%) |
| 2012 | $155.06 M(-45.6%) |
| 2011 | $284.90 M(-23.6%) |
| 2010 | $373.00 M(+161.9%) |
| 2009 | $142.41 M(+238.1%) |
| Date | Value |
|---|---|
| 2008 | $42.12 M(+345.8%) |
| 2007 | $9.45 M(+55.0%) |
| 2006 | $6.10 M(-12.0%) |
| 2005 | $6.93 M(-74.3%) |
| 2004 | $26.90 M(+42.7%) |
| 2003 | $18.84 M(-9.9%) |
| 2002 | $20.91 M(-60.9%) |
| 2001 | $53.49 M(-37.6%) |
| 2000 | $85.70 M(-11.3%) |
| 1999 | $96.66 M(-44.6%) |
| 1998 | $174.32 M(-6.8%) |
| 1997 | $187.06 M(+109.2%) |
| 1996 | $89.41 M(+936.8%) |
| 1995 | $8.62 M(+63.8%) |
| 1994 | $5.26 M(-60.9%) |
| 1993 | $13.47 M(-19.2%) |
| 1992 | $16.68 M |
FAQ
- What is Lineage Cell Therapeutics market capitalization?
- What is the all time high market cap for Lineage Cell Therapeutics?
- What is LCTX market capitalization year-to-date change?
- What is Lineage Cell Therapeutics market cap year-on-year change?
What is Lineage Cell Therapeutics market capitalization?
The current market cap of LCTX is $136.64 M
What is the all time high market cap for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high market capitalization is $486.42 M
What is LCTX market capitalization year-to-date change?
Lineage Cell Therapeutics market capitalization has changed by -$54.09 M (-28.36%) since the beginning of the year
What is Lineage Cell Therapeutics market cap year-on-year change?
Over the past year, LCTX market capitalization has changed by -$38.34 M (-21.91%)